All the news Showing 10 of 22 articles from: Transmission and preventionGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Only treating patients with cirrhosis with DAAs will have limited impact on HCV epidemic in England Michael Carter / 24 May 2016 Targeting new hepatitis C virus (HCV) direct-acting antivirals (DAAs) at patients with cirrhosis will substantially reduce short-term incidence of end-stage liver disease (ESLD) and liver cancer (HCC) in England, according to a model ... A Massive Scale-Up of Hep C Treatment Among Injection Drug Users is Needed to Reap a Prevention Benefit Hepmag / 16 March 2016 Does testing positive for hepatitis C prompt risk reduction? Drug & Alcohol Findings / 22 December 2015 Emergency needle exchange in Indiana reduces HIV and HCV risk for people who inject drugs Liz Highleyman / 30 October 2015 An emergency syringe exchange program implemented after an outbreak of HIV earlier this year in the state of Indiana led to a decrease in risk behaviours including needle sharing during its first five ... Why is injecting equipment re-used? Drug users do their own research to find out Roger Pebody / 22 October 2015 Even in the context of the relatively good access to harm reduction services in Australia, the principle reasons for people who inject drugs to re-use syringes relate to the convenience of services, ... Drug users targeted in bid to stop hep C transmission Sydney Morning Herald / 17 December 2014 Treatment for prevention for hepatitis C in French drug users could cut HCV prevalence by two-thirds in 10 years Keith Alcorn / 12 April 2014 A combination of increased testing, improved linkage to care and treatment immediately after diagnosis with interferon-free regimens has the potential to substantially reduce the incidence and prevalence of hepatitis C virus ... Does paying drug users boost hep B jab uptake? NHS Choices (Behind the Headlines) / 11 April 2014 Testing HCV positive has a sustained impact on drug injecting behaviour Michael Carter / 08 January 2014 Diagnosis with hepatitis C virus (HCV) is associated with a sustained reduction in injecting drug use, according to Canadian research published in the online edition of Clinical Infectious Diseases. Each additional three months ... Behavioural interventions for preventing hepatitis C infection in people who inject drugs: a global systematic review Drug & Alcohol Findings / 09 December 2013 ← Prev123Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive